Registry for patients after myocardial infarction treated with antiplatelet agents in Freiburg.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 28 May 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
Indications Acute coronary syndromes; Myocardial infarction; Stent thrombosis; Stroke
Focus Therapeutic Use
Acronyms MITAP

Most Recent Events

27 Apr 2015 Status changed from planning to completed, according to results published in the Thrombosis and Haemostasis.
12 Jul 2012 Additional trial identifier 193-11, acronym MITAP identified as reported by German Clinical Trials Register record.
06 Jul 2012 Planned initiation date (1 Jul 2011) added as reported by German Clinical Trials Register record.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight